Erratum: Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States
- PMID: 40042262
- PMCID: PMC12337893
- DOI: 10.1200/CCI-25-00026
Erratum: Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States
Erratum for
-
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States.JCO Clin Cancer Inform. 2024 Dec;8:e2400132. doi: 10.1200/CCI.24.00132. Epub 2024 Dec 20. JCO Clin Cancer Inform. 2024. PMID: 39705641 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources